p53 Stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(APF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells

Blood

Volumn 95, Issue 12, 2000, Pages 3939-3944

  Takemoto, Shigeki ^b   Trovato, Raffaella ^b   Cereseto, Anna ^b   Nicot, Christophe ^b   Kislyakova, Tatiana ^b   Casareto, Luca ^b   Waldmann, Thomas ^b   Torelli, Giuseppe ^b   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0034660402     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3939     Document Type: Article

References (37)

1. Gallo RC. The first human retrovirus. Sci Am. 1986;255:88-98.
2. Murphy EL, Hanchard B, Figueroa JP, et al. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250-253.
3. Markham PD, Salahuddin SZ, Kalyanaraman VS, Popovic M, Sarin P, Gallo RC. Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). Int J Cancer. 1983;31:413-420.
4. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T-cells. Nature. 1981;294:770-771.
5. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77: 7415-7419.
6. Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC. Transformation of human umbilical cord blood T-cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A. 1983;80: 5402-5406.
7. Franchini G, Cereseto A, Tryniszewska E, et al. Telomerase activation, rearrangement, and inhibition of cell-cycle inhibitors in human T-cells immortalized or transformed by HTLV-I. In: Semmes OJ, Hammarskjold M-L, eds. Molecular Pathogenesis of HTLV-I: A Current Perspective. Arlington, VA: ABI Professional Publications; 1999: 59-70.
8. waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T-cells. Blood. 1996;88:1551-1560.
9. Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN. Stabilization of wild type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene. 1993;8:3029-3036.
10. Mulloy JC, Kislyakova T, Cereseto A, et al. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol. 1998;72:8852-8860.
11. Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol. 1998;72:6348-6355.
12. Pise-Masison CA, Choi K-S, Radonovich M, Dittmer J, Kim S-J, Brady JN. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol. 1998;72: 1165-1170.
13. Akagi T, Ono H, Tsuchida N, Shimotohno K. Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax 1. FEBS Lett. 1997;406: 263-266.
14. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B, Kastan MB. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA. 1994;91: 2684-2688.
15. Chen JD, Lin JY, Levine AJ. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med. 1995;1:141-142.
16. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296-299.
17. Kubbutat MHG, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997;387: 299-303.
18. Haupt Y, Barak Y, Oren M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 1996;15:1596-1606.
19. Pochampally R, Fodera B, Chen L, Shao W, Levine EA, Chen J. A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells. Oncogene. 1998;17:2629-2636.
20. Erhardt P, Tomaselli KJ, Cooper GM. Identification of the MDM2 oncoprotein as a substrate for CPP32-like apoptotic proteases. J Biol Chem. 1997;272:15,049-15,052.
21. INK4/MTS1 gene transcript expressed in 6-cell malignancies. Oncogene. 1995;11:21-29.
22. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumors. Science. 1994;264:436-440.
23. INK4A transcript. Cancer Res. 1995;55:2995-2997.
24. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
25. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83: 993-1000.
26. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996; 85:27-37.
27. Stone S, Jiang P, Dayanath P, et al. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 1995;55:2988-2994.
28. Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992;80:3205-3216.
29. Sugito S, Yamato K, Sameshima Y, Yokota J, Yano S, Miyoshi I. Adult T-cell leukemia: structures and expression of the p53 mutations. Blood. 1991;49:880-885.
30. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 1995;86:3619-3639.
31. Hirama T, Koeffler HP. Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood. 1995;86:841-854.
32. Jin D-Y, Spencer F, Jeang K-T. Human T-cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 1998;93:1-20.
33. Low KG, Domer LF, Fernando DB, Grossman J, Jeang K-T, Comb MJ. Human T-cell leukemia virus type 1 tax releases cell cycle arrest induced by p16INK4a. J Virol. 1997;71:1956-1962.
34. ink4a and counteracts its inhibitory activity towards CDK4. EMBO J. 1996; 15:1607-1614.
35. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitors INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 1998; 12:845-859.
36. Hatta Y, Yamada M, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia. 1997;11:984-989.
37. INK4A promoter in HTLV-I-infected T-cell lines. AIDS Res Hum Retroviruses. 2000;16:709-713.